Company / Revenue per Share
Q32 Bio Inc. Revenue per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
-
FY2025
5-year range
-$18.50 / $0.59
FY2021-FY2025
Trend
+100.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.06 to $0.00 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue per share increased 100.0% year-over-year.
- Peak revenue per share was recorded in FY2018.
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +100.0% |
| FY2024 | -$18.50 | -33244.9% |
| FY2023 | $0.06 | -90.6% |
| FY2022 | $0.59 | +1005.8% |
| FY2021 | $0.05 | +45.6% |
| FY2020 | $0.04 | -74.1% |
| FY2019 | $0.14 | -89.8% |
| FY2018 | $1.40 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026